No Data
Express News | Renowned Investigators Awarded $8 Million Nih Grant to Study Lucid Diagnostics' Esoguard® in at-Risk Patients Without Symptomatic Gerd
Stifel Maintains Lucid Group(LCID.US) With Hold Rating, Cuts Target Price to $3
Express News | Lucid Group Inc : Stifel Cuts Target Price to $3 From $3.5
Options Market Statistics: Lucid's CEO Steps Down But Forecasts Double Production; Options Pop
Top Gap Ups and Downs on Wednesday: INTU, XPEV, APP and More
Lucid Group Options Spot-On: On February 26th, 490.03K Contracts Were Traded, With 1.41 Million Open Interest
